Muhs university exams answers in easy language
| Type | Example Drugs | Strength |
|---|---|---|
| Loop diuretics | Furosemide, Bumetanide, Torsemide | High (strongest) |
| Thiazides | Hydrochlorothiazide, Metolazone | Medium |
| Carbonic Anhydrase Inhibitors | Acetazolamide | Weak |
| Osmotic Diuretics | Mannitol, Glycerol | Weak/Adjunctive |
| Potassium-sparing | Spironolactone | Weak/Adjunctive |
| Use | Details |
|---|---|
| Raised intracranial pressure (ICP) | Mannitol draws fluid from brain β lowers ICP (head injury, brain tumour) |
| Acute congestive glaucoma | Mannitol 20% IV / Glycerol 50% oral β draws fluid from eye β lowers IOP |
| Prevent acute renal failure | Used in shock, cardiovascular surgery, haemolytic transfusion reactions |
| After dialysis | Maintains osmolality of ECF |
| Use | Detail |
|---|---|
| Hypertension | First-line for essential hypertension |
| Oedema in CHF | Combined with loop diuretics in severe heart failure |
| Hypercalciuria / Kidney stones | Reduce Ca in urine β prevent calcium stones |
| β οΈ Note | Most thiazides NOT effective when GFR is low (except Metolazone) |
| Use | Detail |
|---|---|
| Oedema with high aldosterone | CCF, liver cirrhosis, nephrotic syndrome |
| Moderate-severe Heart Failure (CCF) | Blocks aldosterone effects β prevents hypokalaemia, prevents cardiac remodelling, slows disease progression |
| Combined with thiazides/loop diuretics | Maintains K levels + enhances antihypertensive effect |
| Conn's syndrome | Primary hyperaldosteronism β resistant hypertension |
| Feature | Loop | Thiazide | Spironolactone |
|---|---|---|---|
| Potassium | β (lost) | β (lost) | β (retained) |
| Calcium | β (lost) | β (retained) | β (excreted) |
| Efficacy | Highest | Medium | Low |
| Site | Loop of Henle | Early DCT | Late DCT/CD |
| Key use | Oedema, hypercalcaemia | Hypertension, kidney stones | CCF, hyperaldosteronism |
| Key side effect | Ototoxicity, hypokalaemia | Impotence, hypercalcaemia | Hyperkalaemia |